Skip to main content

Table 3 Hospital-provided treatments (n = 176): The majority report receiving (having received) ointments/creams or hormone therapy (more vaginal suppositories than oral agents)

From: An online survey on coping methods for genitourinary syndrome of menopause, including vulvovaginal atrophy, among Japanese women and their satisfaction levels

Treatment

134 (75%)

 Ointments and creams

71 (40.3%)

 Lubricating jelly

4 (2.3%)

 Local estrogen treatment (vaginal suppository)

15 (8.5%)

 Systematic hormone replacement therapy (HRT)

12 (6.8%)

 Other

32 (18.2%)

No treatment

42 (23.9%)